Hawaii Health Regulators Expand Medical Marijuana Program

HONOLULU, HI — Regulators at the Hawaii Department of Health have agreed to expand the state’s medical cannabis program so that patients diagnosed with Amyotrophic Lateral Sclerosis (aka Lou Gehrig’s disease) may be eligible to access medicinal cannabis.

Citizens petitioned regulators to add both ALS and generalized anxiety disorder to the list of conditions eligible for cannabis therapy.

Advertisement

banners

Department officials concluded that there exists a lack of evidence to support the latter recommendation.

Preclinical models indicate that cannabinoids can alter ALS progression. However, controlled clinical trials evaluating the use of cannabis in patients with ALS have not yet been conducted.

Advertisement

Tags: , , , ,

Advertisement

0 0 vote
Article Rating

Author: admin

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments